Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Which GLP-1RA provides better benefits?
Read More »Comparisons of GLP-1 Agonists
Empagliflozin Produces Liver Fat Reduction in Randomized Control Trial
Could empagliflozin contribute to the early treatment of NAFLD in patients with T2DM?
Read More »The Effects of Type 2 Patients Refusing Insulin
There is a strong need to understand the relationship between the refusal of insulin therapy in patients with type 2 diabetes and worsening blood glucose levels.
Read More »Can ACE Inhibitors Lower Type 2 Diabetes Risk?
ACE inhibitors may have potential uses in diabetes, aside from lowering blood pressure.
Read More »Many People with Type 2 Diabetes Need Better Sleep
Sleep Disorders, HbA1c, and their connection with type 2 diabetes patients.
Read More »Glycemic Variability (GV) Increases Risk For Poorer Outcomes
Maintaining a steady GV through lifestyle, proper treatment regimen, and responsible dietary nutrition can help manage a type 2 diabetic condition.
Read More »Medication Adherence and its Effect on Diabetes Outcomes
Is there a benefit to keeping it “simple” when determining appropriate regimens for patients with diabetes?
Read More »Liraglutide Use in Youth with Type 2 Diabetes
Results from a phase 3 trial investigating the use of liraglutide in children and adolescents.
Read More »Duodenal Mucosal Resurfacing as a Treatment Option for Type 2 Diabetes
A new, less invasive take on bariatric surgery may hold promise in the treatment of type 2 diabetes.
Read More »Beverage Choices and Their Effects on Risk of Developing Diabetes
How much can one drink matter? Quite a bit, as it turns out.
Read More »